Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news


From To
The final frontier in the fight against Aids? There is still one region where HIV infection rates are on the rise

Huge global progress has been made in tackling an epidemic which has claimed over 35 million lives since the 1980s. But there’s one region in the world where infection rates from the human immunodeficiency virus (HIV) – the pathogen that causes Aids – have been quietly rising in recent years. The HIV crisis in eastern Europe and central Asia – which gathered pace in the two decades following the disintegration of the Soviet Union in 1991 – has now reached epidemic proportions.

20 hours ago
Daily Telegraph
When we find a cure, price it like Netflix to ensure access

An essential lesson from the successful fight against AIDS is that early access to effective treatment can avoid long-term costs. For hepatitis C treatment, Louisiana may have found a solution. The Department of Health is working on a new strategy to expand access—one that involves a licensing deal. The state would agree to pay a drug company for medication for several years in exchange for unlimited access to treatment.

13 August 2018
The Hill
South Africa strikes deal on new TB drug as WHO revisits guidance

The World Health Organization could soon start promoting a new tuberculosis drug that is now more affordable after South Africa brokered a deal with a pharmaceutical company to slash the price by half.

13 August 2018
Unable to Get Meds, Venezuelans With HIV Turn to Guásimo

An economic crisis is leading to desperation, DIY treatments and death.

10 August 2018
Fast Track Cities Quality of Life Survey

We invite people living with HIV in 29 cities to complete a 10-minute online survey that will can assist us in better understanding the quality of life issues that impact urban AIDS responses. Your name will remain anonymous, but through your input you will have a positive effect on the quality of life of the global community of people living with HIV. The 29 cities include Amsterdam, Athens, Atlanta, Bamako, Bangkok, Berlin, Brussels, Bucharest, Buenos Aires, Dar es Salaam, Denver, Durban, Geneva, Kingston, Lisbon, Libreville, Madrid, Melbourne, Miami, Montréal, Nairobi, New Orleans, New York City, Oakland, Paris, Rio de Janeiro, Salvador de Bahia, San Francisco, and Santiago. UK Fast Track cities (Brighton and London) can fill it in by checking "other".

09 August 2018
Price Of HIV Viral Load Test Falls, Raising Hopes In Global AIDS Fight

The Clinton Health Access Initiative, along with several other development agencies, has brokered an agreement to make routine HIV tests more accessible. They're aiming to make HIV viral load tests available for $12 a piece, slashing the price in some markets by more than 50 percent.

02 August 2018
Game over for Gilead’s monopoly on Truvada

The judge of the Court of Justice of the European Union has just returned his verdict: the patent extension granted to Gilead on Truvada in many European countries is now illegal. AIDES has questioned the Intellectual Property misuses of the company for two years and welcomes this European ruling for three reasons: for healthcare systems users, for the sustainability of public budgets and for access to PrEP all over Europe.

30 July 2018
Supervised drug consumption sites offer opportunities for HCV testing and treatment

Most supervised drug consumption facilities offer hepatitis C virus (HCV) testing and referrals, but very few offer treatment, indicating that they could potentially play a greater role in

27 July 2018
Liz Highleyman
Terrence Higgins Trust launches Access Fund to support people who can’t afford HIV prevention drug PrEP

The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland.

26 July 2018
Terrence Higgins Trust
UK HIV drugs bill may reduce following court ruling - implications for PrEP

A ruling today from the European Court of Justice (ECJ) suggests that Gilead’s patent for Truvada (the drug used to treat many people living with HIV, and the drug used for PrEP) may be under threat.

25 July 2018
National AIDS Trust
← First12345...136Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.